Gemphire Therapeutics Inc. (48) | Uncategorized (12)

Recent Contracts

Description of Securities (Filed With SEC on April 15, 2021)
First Amendment to Contingent Value Rights Agreement, dated as of December 30, 2019, by and among NeuroBo, the Holders Representative, and the Rights Agent, dated as of March 23,... (Filed With SEC on March 24, 2021)
Form of Support Agreement (Filed With SEC on January 6, 2021)
Form of Lock-Up Agreement (Filed With SEC on January 6, 2021)
Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated November 11, 2020 (Filed With SEC on November 13, 2020)
Description of Securities (Filed With SEC on March 30, 2020)
Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated January 9, 2020 (Filed With SEC on March 30, 2020)
Offer Letter, dated as of January 29, 2020, by and between Nicola Shannon and NeuroBo Pharmaceuticals, Inc (Filed With SEC on March 30, 2020)
Offer Letter, dated as of August 20, 2018, by and between Nicola Shannon and NeuroBo (Filed With SEC on December 31, 2019)
Independent Contractor Agreement by and between Therabo PLLC and NeuroBo Pharmaceuticals, Inc., dated March 1, 2019 (Filed With SEC on September 3, 2019)
Fourth Amended and Restated Stockholders' Agreement, by and among the Initial Holders and the Investors on Schedule A thereto and NeuroBo Pharmaceuticals, Inc., dated May 30, 2019 (Filed With SEC on September 3, 2019)
Acquisition Agreement by and between Dong-A ST Co., Ltd. and NeuroBo Pharmaceuticals, Inc., dated January 18, 2018, as amended on April 18, 2018 and July 24, 2019 (Filed With SEC on September 3, 2019)